Advertisement

Early generation transcatheter aortic valve implants durable and effective 5 years after treatment, researchers found.

MassDevice On Call

MASSDEVICE ON CALL — Results from the one of the 1st in-human studies of transcatheter aortic valve implants proved that the devices remained durable and effective 5 years after treatment, researchers found.

The study, which included 111 patient implanted with either Edwards Lifesciences (NYSE:EW) Sapien valve or the Cribier-Edwards valve, was the 1st study of transapical and transarterial TAVI devices in inoperable patients, TheHeart.org reported.

Advertisement
Advertisement